Was on the Dales Report to talk about the Reefer Madness Influencer campaign this week. The topic of CHS came up. The 2.75M number the NYT quoted but had no citation and is not a reliable number. Derived from 555 patients from 1 hospital and extrapolated to entire populations. It did not use ROME IV diagnostic criteria. CHS is in fact primarily a CB1 agonist issue but there are still a minority of patients that report switching strains and it going away. One hypothesis for these exceptions is Vomitoxin from Fusarium.

The Dales Report
@TheDalesReport
02-13
🎦 TRADE TO BLACK 📊 Presented by @FlowhubCo 🕓 *LIVE* @ 4pm ET 🎦 The Media Narrative Turning Against Marijuana 🎙️ @FundCanna CEO Adam Stettner @AdamStettner 🎙️ Medicinal Genomics CSO Kevin McKernan @Kevin_McKernan 🌿 ETFs: 🌎 $YOLO 🇺🇸 $MSOS https://youtube.com/live/g9hsIpYJSf0?si=xUNqDrTNHfwDPCpx…
From Twitter
Disclaimer: The content above is only the author's opinion which does not represent any position of Followin, and is not intended as, and shall not be understood or construed as, investment advice from Followin.
Like
Add to Favorites
Comments